MercerRx Passage

Unified, accurate and fair

Our proprietary pharmacy rate-setting platform provides greater insight and transparency.

Download the fact sheet

Pharmacy rate setting

Multiple sources of data are now funneled and connected through a single-source of truth.

Watch the demo

A more unified approach

Best-in-class technology allows us to respond rapidly to market fluctuations and nimbly adjust to changes in our clients reimbursement approach.

ADURS Symposium Presentation

New Drug Update - February 2024

A review of notable therapies approved by the FDA within the last year.
Pharmacy Update

Cell & Gene Therapy Access Model

A review of the CGT Access Model and its role in prioritizing gene therapies for the treatment of sickle cell disease.
Pharmacy Update

New Therapies for Sickle Cell Disease

A review of two new gene therapies used to treat Sickle Cell Disease.
EMPAA Conference Presentation

New Drug Update - August 2023

Discusses gene and cellular therapies, biosimilars, oncology, FDA new drug approval patterns, and more.
SAMPA Annual Meeting Presentation

Unstable Ground

Market drug changes and the Medicaid implications, considerations for OTC, and a discussion on insulin price changes.
SOA Health Meeting Presentation

Emerging Pharmacy Trends

How commercial, Medicare, and Medicaid programs are navigating the challenges these trends present.
Pharmacy Update

FDA Approvals and Market Updates

An in-depth review of recent FDA approvals and market updates, including considerations for states.
Pharmacy Update

Advance Rx Drug Transparency

A summary of key information from the CMS proposed rule aimed at lowering prescription drug costs in Medicaid.
Pharmacy Update

Obesity Management Medications

Review of weight management medications and their impact on state Medicaid programs
Pharmacy Update

First Humira biosimilar

Our review of Amjevita, the first Humira biosimilar, the 2023 biosimilar pipeline, and the impact to Medicaid.
Pharmacy Update

Digital Therapeutics and Medicaid

Digital Therapeutics present challenges and opportunities for Medicaid programs

$348B

Prescription drug spend in 2020 reported by CMS1

$1.49B

gross Medicaid spending on the 50 most expensive drugs in 20191

The challenge

State Medicaid programs are obligated to provide the most recent drugs to beneficiaries while balancing the limited state budgets and the sky-rocketing cost of specialty drugs.

MercerRx Government provides the cost-saving strategies you need.

 

Providing you direction to enlightened analytics

Introducing MercerRx Passage

Our proprietary pharmacy rate-setting platform provides greater insight and transparency. This best-in-class technology allows us to respond rapidly to market fluctuations and nimbly adjust to changes in our clients reimbursement approach. Multiple sources of data are now funneled and connected through a single source of truth. This results in more unified, accurate and fair rate calculations. MercerRx Passage provides the balance:

Drugs Icon

Your Medicaid providers want fair and equitable reimbursement

MercerRx Passage is a central resource for providers to submit their invoices or rate inquires - an easy Passage!

 

Magnifying Glass Icon

Your Medicaid beneficiaries need access to the care they require

MercerRx Passage is a client dashboard that highlights survey and rate metrics as well as trends to help determine coverage options - spotlight Passage!

 

Cash Icon

You must achieve the state's financial and budgetary goals

MercerRx Passage is a rate calculation application that increases the accuracy and efficiency resulting in more defensible rates​ - your Passage

 

MercerRx Passage

Schedule a personalized demo today.

Additional Pharmacy Resources

Stay informed with our insights on the latest Medicaid news 

pharmacy presentation

the intersection of 340B and Medicaid

Sara Drake, RPh, MPH, MBA, shares the challenges at the intersection of Medicaid and 340B.

https://www.mercer-government.mercer.com/content/dam/mercer-subdomains/us-government/attachments/New/RJN_EPR_II_Medicaid_and_340B_AMCP.pdfDownload the presentation
Our thinking

Gene and cell therapy

Our insights and strategies around the rise of million dollar drug treatments

https://www.mercer.us/our-thinking/healthcare/gene-and-cell-therapy-the-rise-of-million-dollar-drug-treatments.htmlRead more
Medicaid news & more

Stay informed

We provide key insights and timely updates on Medicaid and public health important to states

https://www.mercer-government.mercer.com/medicaid-news-and-more.html#contactFormSubscribe here

Ready to live better, 

work brighter?

Speak with one of our HR consultants.

1 CVS Caremark 2020 Drug Trend Report
2 Rx Price Watch Report: Trends in Retail Prices of Specialty Prescription Drugs Widely Used by Older Americans, 2006 to 2020
* Results may vary

Speak with a Consultant

Learn more about our pharmacy strategies for state Medicaid programs or to see a personalized demo of MercerRx Passage.

*Required Fields

Fact Sheets

Blogs

Videos

Solutions

© 2024 Mercer LLC, All Rights Reserved